JAZZ:NASDAQ
Jazz Pharmaceuticals PLC
209,65 US$
arrow_downward
−0,35%(−0,74) 1 d
209,65 US$
0,00% (0,00)
bedtimeEfter stängning
Stängd: 14 okt., 16:00:01 GMT−4 · USD
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för JAZZ …
Öppen
210,34 US$
Högt
215,66 US$
Lågt
209,36 US$
Börsvärde
13,61 md
Genomsn. vol.
791,77 tn
Volym
0,00
P/E-tal
14,33
52v högst
266,38 US$
52v lägst
128,80 US$
EPS
14,63 US$
Beta
0,37
Utestående aktier
64,92 mn
Antal anställda
3 tn
Öppen
210,34 US$
Högt
215,66 US$
Lågt
209,36 US$
Börsvärde
13,61 md
Genomsn. vol.
791,77 tn
Volym
0,00
P/E-tal
14,33
52v högst
266,38 US$
52v lägst
128,80 US$
EPS
14,63 US$
Beta
0,37
Utestående aktier
64,92 mn
Antal anställda
3 tn
Nyheter och artiklar
Från webbkällor och nyhetspartner
Benzinga
·
för 2 dagar sedan
Jim Cramer Gives Green Light To This Health Care Stock
https://www.dars.gov.et/
·
för 2 månader sedan
Jazz Pharmaceuticals (JAZZ) Holds Steady at $256.52 as Shares Trade Flat - FRAMA Signal
Profil
Jazz Pharmaceuticals plc is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
One of the company's considerable products is the United States Food and Drug Administration approved drug Xyrem, the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid. In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness in narcolepsy as well as obstructive sleep apnea. In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.
In 2007, the company pled guilty to felony charges related to its illegal marketing of Xyrem for off-label use.
The company is also a member of the Pharmaceutical Research and Manufacturers of America. Wikipedia
Om Jazz Pharmaceuticals PLC